Ascletis reports positive phase Ib results for oral GLP-1R agonist ASC30 at EASD 2025
The Phase Ib MAD study is a randomized, double-blind, placebo-controlled trial conducted in the United States
The Phase Ib MAD study is a randomized, double-blind, placebo-controlled trial conducted in the United States
Dilip Shanghvi to continue as the Executive Chairman of the Board
The conference featured comprehensive discussions, field visits, and knowledge-sharing sessions addressing different aspect of major NCDs
Ursodeoxycholic acid or ursodiol is a naturally occurring bile acid that is used dissolve cholesterol gall stones
Augtyro is the only FDA-approved treatment option for NTRK-positive tumors studied in both TKI-naïve and TKI-pretreated patients across solid tumors
The product will be manufactured at Lupin's Pithampur facility in India
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed
The Elecsys Amyloid Plasma Panel has the potential to ensure better identification of patients that require further confirmatory testing, supporting a more timely and accessible diagnosis.
New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity
Subscribe To Our Newsletter & Stay Updated